icon-    folder.gif   Conference Reports for NATAP  
 
  Presented at the 22nd Conference of the Asian Pacific Association for the Study of the Liver (APASL)
Taipei, Taiwan
February 16-19, 2012
Back grey_arrow_rt.gif
 
 
 
BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C VIRUS GENOTYPE-1 INFECTED ASIAN PATIENTS IN THE SPRINT-1, SPRINT-2, AND RESPOND-2 TRIALS
 
 
  Reported by Jules Levin
 
Presented at the 22nd Conference of the Asian Pacific Association for the Study of the Liver, February 16-19, 2012, Taipei City, Taiwan
 
K.Q. HU,1 F. ALVAREZ BOGNAR,2 S. THOMPSON,2 L. PEDICONE,2 J. WAHL,2 S.G. LIM3 1UNIVERSITY OF CALIFORNIA, IRVINE MEDICAL CENTER, ORANGE, CA, USA; 2MERCK SHARP & DOHME, WHITEHOUSE STATION, NJ, USA; 3NATIONAL UNIVERSITY HOSPITAL, SINGAPORE

APSL1.gif

APSL2.gif

APSL3.gif

APSL4.gif

APSL5.gif

APSL6.gif

APSL7.gif

APSL8.gif